Clinical Trial Update: Prevention of Persistence of Bacterial Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial studying prevention of persistence of bacterial vaginosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Snippet

Sponsor: Embil Pharmaceutical Co. Ltd | Conditions: Bacterial Vaginosis | Phase 3 | Status: TERMINATED